Yüklüyor......
Comparative Resistance to Teriparatide-Induced Bone Resorption With Denosumab or Alendronate
CONTEXT: In postmenopausal osteoporotic women, denosumab fully inhibits teriparatide-induced bone resorption at approved doses. This property of denosumab is distinct from that of alendronate and likely contributes to the efficacy of combination denosumab and teriparatide therapy. Whether denosumab...
Kaydedildi:
| Yayımlandı: | J Clin Endocrinol Metab |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Endocrine Society
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5393530/ https://ncbi.nlm.nih.gov/pubmed/25933031 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2015-1541 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|